Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xilei Ai

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|January 27, 2025
Aptazyme-directed A-to-I RNA editingXilei Ai, Zhuo Tang
Journal of Cellular Biochemistry|April 12, 2022
Trans-cleaving hammerhead ribozyme in specific regions can improve knockdown efficiency in vivoYan Peng, Xilei Ai, Bo Peng
Stem Cell Reviews and Reports|June 30, 2025
Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug ScreeningJihong Liu, Wanlin Zhao, Zijuan Zhang, et al.
Analytica Chimica Acta|May 15, 2022
Organelle-targeted imaging based on fluorogen-activating RNA aptamers in living cellsYan Peng, Xilei Ai, Yi Yuan, et al.
ACS Synthetic Biology|June 29, 2023
Leveraging Small Molecule-Induced Aptazyme Cleavage for Directed A-to-I RNA EditingXilei Ai, Shan Zhou, Meiyi Chen, et al.
Molecular Therapy. Nucleic Acids|February 19, 2025
Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAsXilei Ai, Sheng Ding, Shan Zhou, et al.
Experimental Cell Research|June 17, 2019
The protective role of the MKP-5-JNK/P38 pathway in glucolipotoxicity-induced islet β-cell dysfunction and apoptosisZhuoyao Song, Jie Ma, Yuanhua Lu, et al.
Molecular Therapy. Nucleic Acids|August 7, 2023
<i>Trans-</i>acting aptazyme for conditional gene knockdown in eukaryotic cellsShan Zhou, Meiyi Chen, Yi Yuan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|January 27, 2025
Aptazyme-directed A-to-I RNA editingXilei Ai, Zhuo Tang
Journal of Cellular Biochemistry|April 12, 2022
Trans-cleaving hammerhead ribozyme in specific regions can improve knockdown efficiency in vivoYan Peng, Xilei Ai, Bo Peng
Stem Cell Reviews and Reports|June 30, 2025
Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug ScreeningJihong Liu, Wanlin Zhao, Zijuan Zhang, et al.
Analytica Chimica Acta|May 15, 2022
Organelle-targeted imaging based on fluorogen-activating RNA aptamers in living cellsYan Peng, Xilei Ai, Yi Yuan, et al.
ACS Synthetic Biology|June 29, 2023
Leveraging Small Molecule-Induced Aptazyme Cleavage for Directed A-to-I RNA EditingXilei Ai, Shan Zhou, Meiyi Chen, et al.
Molecular Therapy. Nucleic Acids|February 19, 2025
Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAsXilei Ai, Sheng Ding, Shan Zhou, et al.
Experimental Cell Research|June 17, 2019
The protective role of the MKP-5-JNK/P38 pathway in glucolipotoxicity-induced islet β-cell dysfunction and apoptosisZhuoyao Song, Jie Ma, Yuanhua Lu, et al.
Molecular Therapy. Nucleic Acids|August 7, 2023
<i>Trans-</i>acting aptazyme for conditional gene knockdown in eukaryotic cellsShan Zhou, Meiyi Chen, Yi Yuan, et al.
Pageof 1